Concepts (78)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Axilla | 4 | 2017 | 109 | 0.750 |
Why?
|
| Breast Neoplasms | 11 | 2026 | 3110 | 0.720 |
Why?
|
| Sentinel Lymph Node Biopsy | 2 | 2017 | 86 | 0.540 |
Why?
|
| Breast Diseases | 2 | 2017 | 99 | 0.520 |
Why?
|
| Breast | 2 | 2021 | 294 | 0.490 |
Why?
|
| Positron Emission Tomography Computed Tomography | 1 | 2017 | 104 | 0.490 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2017 | 149 | 0.490 |
Why?
|
| Lymph Nodes | 2 | 2017 | 548 | 0.460 |
Why?
|
| Neoadjuvant Therapy | 3 | 2026 | 446 | 0.440 |
Why?
|
| Ultrasonography | 1 | 2017 | 702 | 0.440 |
Why?
|
| Magnetic Resonance Imaging | 8 | 2026 | 3476 | 0.420 |
Why?
|
| Contrast Media | 6 | 2026 | 988 | 0.380 |
Why?
|
| Lymphatic Metastasis | 3 | 2017 | 504 | 0.270 |
Why?
|
| Ultrasonography, Mammary | 3 | 2013 | 82 | 0.240 |
Why?
|
| Mammography | 3 | 2021 | 458 | 0.180 |
Why?
|
| Receptor, ErbB-2 | 1 | 2023 | 280 | 0.170 |
Why?
|
| Mastectomy, Segmental | 1 | 2021 | 107 | 0.160 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2026 | 1261 | 0.150 |
Why?
|
| Mass Screening | 3 | 2019 | 696 | 0.140 |
Why?
|
| BRCA1 Protein | 1 | 2018 | 214 | 0.130 |
Why?
|
| Female | 15 | 2026 | 48698 | 0.130 |
Why?
|
| Middle Aged | 12 | 2026 | 27569 | 0.120 |
Why?
|
| Radiopharmaceuticals | 1 | 2017 | 203 | 0.120 |
Why?
|
| Feasibility Studies | 1 | 2017 | 756 | 0.110 |
Why?
|
| Sensitivity and Specificity | 6 | 2023 | 1922 | 0.110 |
Why?
|
| Aged | 9 | 2026 | 20430 | 0.110 |
Why?
|
| Early Detection of Cancer | 1 | 2018 | 482 | 0.100 |
Why?
|
| Adult | 10 | 2026 | 27918 | 0.100 |
Why?
|
| Diagnosis, Differential | 1 | 2017 | 1546 | 0.100 |
Why?
|
| Retrospective Studies | 5 | 2026 | 10164 | 0.090 |
Why?
|
| Humans | 15 | 2026 | 93511 | 0.090 |
Why?
|
| Aged, 80 and over | 3 | 2017 | 7061 | 0.080 |
Why?
|
| Hemangioma | 1 | 2010 | 63 | 0.080 |
Why?
|
| Enteritis | 1 | 2009 | 23 | 0.070 |
Why?
|
| Biopsy, Needle | 1 | 2008 | 225 | 0.070 |
Why?
|
| Ultrasonography, Interventional | 1 | 2008 | 119 | 0.070 |
Why?
|
| Gadolinium DTPA | 3 | 2014 | 233 | 0.070 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2009 | 297 | 0.060 |
Why?
|
| Reflex, Startle | 1 | 2006 | 32 | 0.060 |
Why?
|
| Prospective Studies | 3 | 2021 | 4560 | 0.050 |
Why?
|
| Cluster Analysis | 1 | 2026 | 391 | 0.050 |
Why?
|
| Cerebrovascular Circulation | 1 | 2006 | 239 | 0.050 |
Why?
|
| Neoplasm Staging | 3 | 2018 | 2017 | 0.050 |
Why?
|
| Liver Neoplasms | 1 | 2010 | 776 | 0.050 |
Why?
|
| Hemodynamics | 1 | 2006 | 713 | 0.050 |
Why?
|
| Crohn Disease | 1 | 2009 | 808 | 0.050 |
Why?
|
| Prognosis | 2 | 2026 | 3910 | 0.040 |
Why?
|
| Biopsy | 2 | 2018 | 1175 | 0.040 |
Why?
|
| Kinetics | 1 | 2023 | 1492 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2010 | 2585 | 0.040 |
Why?
|
| Logistic Models | 1 | 2019 | 1243 | 0.030 |
Why?
|
| Comorbidity | 1 | 2019 | 1007 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 1847 | 0.030 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2026 | 2544 | 0.030 |
Why?
|
| Meglumine | 1 | 2014 | 36 | 0.030 |
Why?
|
| Reproducibility of Results | 2 | 2010 | 2715 | 0.030 |
Why?
|
| Organometallic Compounds | 1 | 2014 | 139 | 0.020 |
Why?
|
| Fats | 1 | 2011 | 12 | 0.020 |
Why?
|
| Time Factors | 1 | 2019 | 5410 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2023 | 9098 | 0.020 |
Why?
|
| Radiography | 1 | 2011 | 790 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2018 | 2465 | 0.020 |
Why?
|
| Incidental Findings | 1 | 2010 | 97 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2013 | 1713 | 0.020 |
Why?
|
| Carcinoma, Ductal | 1 | 2008 | 18 | 0.020 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 2008 | 36 | 0.020 |
Why?
|
| Image Enhancement | 1 | 2011 | 505 | 0.020 |
Why?
|
| Carcinoma, Lobular | 1 | 2008 | 84 | 0.020 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 1 | 2008 | 122 | 0.020 |
Why?
|
| Lymph Node Excision | 1 | 2008 | 233 | 0.020 |
Why?
|
| Mutation | 1 | 2018 | 4272 | 0.020 |
Why?
|
| Adipose Tissue | 1 | 2008 | 270 | 0.010 |
Why?
|
| Acoustic Stimulation | 1 | 2006 | 130 | 0.010 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2010 | 626 | 0.010 |
Why?
|
| Risk Factors | 1 | 2014 | 5898 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2008 | 1448 | 0.010 |
Why?
|
| Male | 3 | 2010 | 44553 | 0.010 |
Why?
|
| Oxygen | 1 | 2006 | 769 | 0.010 |
Why?
|